The WHO, UNICEF and Rotary International on Thursday announced they will kick off a “mass polio immunization campaign in three Central African nations” on Friday “in response to a polio outbreak suspected in more than 100 deaths and deemed ‘unusual’ because it targets adults more than children,” that was first confirmed in the Republic of Congo on Nov. 4, the Associated Press reports.
Pneumonia Report Card Shows Prevention, Treatment Tools Not Widely Adopted In Countries Where Disease Kills Most Children
In advance of World Pneumonia Day, the International Vaccine Access Center (IVAC) on Thursday released a report card (.pdf) showing that pneumonia prevention and intervention targets are not being met in the 15 countries where three-quarters of deaths in children under age 5 from the disease occur each year, IRIN reports (11/11).
“Drugmakers are now working on over 100 R&D projects designed to tackle diseases of the developing world and almost 80% of them are being carried out with non-industry partners,” according to a report (.pdf) released on Wednesday by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), Pharma Times reports.
Also In Global Health News: Rice Research Initiative; Kala Azar In Sudan; R&D In Developing Countries; Indian Measles Vaccination Campaign
Global Rice Research Initiative Launched At International Rice Congress “The world’s leading rice research institutions are joining forces to improve rice yields and breed improved varieties â€¦ to help to secure future affordable food supplies for the world’s poorest people,” Nature News writes in an article that examines the “$600…
Nature News reports on an immunization campaign kicking off in Africa in December that will offer protection to some areas of Africa’s meningitis belt. “Millions will receive a new vaccine, MenAfriVac, that promises protection against the meningococcal bacterium Neisseria meningitides,” the news service writes, noting the effort “is the culmination of ten years’ work by an international consortium to develop a vaccine at a price low enough for massive use in Africa: just US$0.40 a dose.”
“Using mobile-phone text messages to remind HIV patients to take their dose of life-saving medications can give a major boost to drug adherence, according to an innovative trial in Kenya unveiled on Tuesday,” Agence France-Presse reports.
Also In Global Health News: Congo Polio Outbreak; Aid Groups Ordered Closed In Afghanistan; Subsidized Malaria Drugs In Kenya; Gates Grand Challenges; Contraception In The Philippines
Polio Outbreak In Congo Leads To Emergency Immunization Effort “Eighty-five deaths and 184 cases of paralysis were reported in the port city of Pointe Noire, the epicenter of the Republic of Congo’s first polio outbreak in a decade, the World Health Organization said in a statement yesterday,” Bloomberg reports. “The…
Also In Global Health News: Preventing Bioterrorism; Condom Use In Thailand; Stunted Growth Among Nepalese Children; Measles Vaccination In Ghana; BBC Apologizes For Live Aid Reports
Lugar, Pentagon Officials Head To Africa For Laboratory Inspections In a Foreign Policy blog post, David Hoffman reports that Sen. Richard Lugar (R-Ind.) and several Pentagon officials will travel to Kenya and Uganda this week to inspect laboratories thatÂ “are working on infectious disease diagnosis and treatment; the concern is that…
Scientists Identify Genes That Enable Some Immune Systems To Halt HIV; Finding Could Spur Drug, Vaccine Development
“Tiny variants in a protein that alerts the body to infection could explain how one in 300 HIV-infected people are able to resist the onset of AIDS for years without needing any treatment, researchers said Thursday” in a study published online in the journal Science, Agence France-Presse reports (11/4). “The findings are encouraging for the development of vaccines because they tell scientists how the immune system might be manipulated to fend off HIV,” the Independent writes (Connor, 11/5).
Sanofi Pasteur, the vaccines division of the pharmaceutical group Sanofi-Aventis, on Thursday announced the company had begun testing its dengue fever vaccine in a Phase III clinical trial in Australia, Dow Jones/Wall Street Journal reports. “Sanofi-Aventis already performed earlier clinical tests on children and adults with the vaccine in the U.S., Asia and Latin America,” Dow Jones/Wall Street Journal adds (Landauro, 11/4).